Macular pigment: A review of current knowledge

Archives of Ophthalmology

Volumn 124, Issue 7, 2006, Pages 1038-1045

  Whitehead, A Jeffrey ^a   Mares, Julie A ^a   Danis, Ronald P ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CAROTENOID; CARRIER PROTEIN; XANTHOPHYLL; ZEAXANTHIN;

ANTIOXIDANT ACTIVITY; BLUE LIGHT; CHOROID CAPILLARY LAYER; COLOR VISION; DIET; DIET SUPPLEMENTATION; DOSE RESPONSE; HUMAN; IN VIVO STUDY; METABOLISM; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; VISUAL ACUITY;

CAROTENOIDS; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; RETINAL PIGMENTS;

EID: 33745809894     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.7.1038     Document Type: Review

References (104)

1. Home E. An account of the orifice in the retina of the human eye, discovered by Professor Soemmering: to which are added proofs of this appearance being extended to the eyes of other animals. Philos Trans R Soc Lond. 1798(pt 2):332.
2. Buzzi F. Nuove sperienze fatte sulli occhio umano. Opuscoli Scetti Sulle Scienze e Sulle Arti. 1782;5:87.
3. Soemmering S. De foramina centrali limbo luteo cincto retinae humanae. Comment Soc Reg Sci Goetting. 1799;13.
4. Wolin LR, Massopust LC. Characteristics of the ocular fundus in primates. J Anat. 1967;101:693-699.
5. Wald G. Human vision and the spectrum. Science. 1945;101:653-658.
6. Weale RA. Hue discrimination in paracentral parts of the human retina measured at different luminance levels. J Physiol. 1951;113:115-122.
7. Brown PK, Wald G. Visual pigments in human and monkey retinas. Nature. 1963;200:37-43.
8. Ruddock KH. Evidence for macular pigmentation from colour matching data. Vision Res. 1963;61:417-429.
9. Hartridge H. Macular pigment. Nature. 1951;167:76-77.
10. Goodwin TW. The Biochemistry of the Carotenoids. London, England: Chapman & Hall; 1980.
11. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25:1531-1535.
12. Snodderly DM, Auran JD, Delori FC. The macular pigment, II: spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:674-685.
13. Weiser H, Kormann AW. Provitamin A activities of carotenoids and physical functions in animals. Ann N Y Acad Sci. 1993;691:213-215.
14. Müller H. Die tagliche Aufnahme von Carotinoiden (Carotine und Xanthophylle) aus Gesamtnahrungsproben und die Carotinoidgehalte ausgewahlter Gemuse-und Obstarten. Z Ernahrungswiss. 1996;35:45-50.
15. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2001;153:424-432.
16. Erdman JW Jr, Bierer TL, Gugger ET. Absorption and transport of carotenoids. N Y Acad Sci. 1993;691:76-85.
17. Broekmans WM, Berendschot TT, Klopping-Ketelaars IA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr. 2002;76:595-603.
18. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795-1801.
19. Zaripheh S, Erdman JW Jr. Factors that influence the bioavailability of xanthophylls. J Nutr. 2002;132:531S-534S.
20. Khachik F, Spangler CJ, Smith JC Jr, Canfield LM, Steck A, Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem. 1997;69:1873-1881.
21. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem. 1990;8:1-10.
22. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447-49454.
23. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci. 1997;38:167-175.
24. Yemelyanov AY, Katz NB, Bernstein PS. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res. 2001;72:381-392.
25. Snodderly DM, Handelman GJ, Adler AJ. Distribution of macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci. 1991;32:268-279.
26. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment, I: absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-673.
27. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850-855.
28. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci. 1993;34:2033-2040.
29. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211-218.
30. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci. 1988;29:843-849.
31. Sujak A, Okulski W, Gruszecki WI. Organisation of xanthophyll pigments lutein and zeaxanthin in lipid membranes formed with dipalmitoylphosphatidylcholine. Biochim Biophys Acta. 2000;1509:255-263.
32. Robson AG, Harding G, van Kuijk FJ, et al. Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception. 2005;34:1029-2034.
33. Hammond BR Jr, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci. 1992;33:350-355.
34. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T; CAREDS Macular Pigment Study Group. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the Carotenoids and Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci. 2004;45:531-538.
35. Bernstein PS, Yoshida MD, Katz N, McClane RW, Gellerman W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci. 1998;39:2003-2011.
36. Johnson EJ, Hammond BR, Russell RM, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
37. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322-3326.
38. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992-998.
39. Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873-1881.
40. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplementation in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004;79:21-27.
41. van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr. 2000;130:503-506.
42. Hammond BR Jr, Caruso-Avery M. Macular pigment optical density in a southwestern sample. Invest Ophthalmol Vis Sci. 2000;41:1492-1497.
43. Hammond BR Jr, Curran-Celentano J, Judd S, et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res. 1996;36:2001-2012.
44. Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr. 2001;74:796-802.
45. Nolan J, O'Donovan O, Kavanagh H, et al. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci. 2004;45:3940-3950.
46. Hammond BR Jr, Fuld K, Snodderly DM. Iris color and macular pigment optical density. Exp Eye Res. 1996;62:293-297.
47. Ciulla TA, Curran-Celantano J, Cooper DA, et al. Macular pigment optical density in a midwestern sample. Ophthalmology. 2001;108:730-737.
48. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
49. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton M. Macular pigment and risk of age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.
50. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study [published correction appears in Invest Ophthalmol Vis Sci. 2001;42:548]. Invest Ophthalmol Vis Sci. 2001;42:235-240.
51. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1708.
52. Khachik F, Spangler CJ, Smith JC Jr, Canfield LM, Steck A, Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem. 1997;69:1873-1881.
53. Howarth PA, Bradley A. The longitudinal chromatic aberration of the human eye and its correction. Vis Res. 1986;26:361-366.
54. Walls GL, Judd HD. The intraocular colour filters of vertebrates. Br J Ophthalmol. 1933;17:641-675, 705-725.
55. Gilmartin B, Hogan RE. The magnitude of longitudinal chromatic aberration in the human eye between 458 and 633 nm. Vision Res. 1985;25:1747-1753.
56. Wooten BR, Hammond BR. Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res. 2002;21:225-240.
57. Bone RA, Landrum JT. Macular pigment in Henle fiber layer as a model for Haidinger's brushes. Vision Res. 1984;24:103-108.
58. Boettner EA, Wolter JR. Transmission of the ocular media. Invest Ophthalmol Vis Sci. 1962;1:776-783.
59. Campbell FW, Gubisch RW. Optical quality of the human eye. J Physiol. 1966;186:558-578.
60. Hammond BR Jr, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:397-406.
61. Werner JS, Peterzell DH, Scheetz AJ. Light, vision, and aging. Optom Vis Sci. 1990;67:214-229.
62. Hammond BR Jr, Wooten BR, Curran-Celentano J. Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys. 2001;385:41-46.
63. Young RW. The family of sunlight-related eye diseases. Optom Vis Sci. 1994;71:125-144.
64. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:e32.
65. Conn PF, Schalch W, Truscott TG. The singlet oxygen and carotenoid interaction [published correction appears in J Photochem Photobiol B. 1993;17:89]. J Photochem Photobiol B. 1991;11:41-47.
66. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci. 1992;33:3497-3499.
67. Gottsch JD, Pou S, Bynoe LA, Rosen GM. Hematogenous photosensitization: a mechanism for the development of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1990;31:1674-1682.
68. Gottsch JD, Bynoe LA, Harlan JB, Rencs EV, Green WR. Light-induced deposits in Bruch's membrane of protoporphyric mice. Arch Ophthalmol. 1993;111:126-129.
69. Bynoe LA, Gottsch JD, Pou S, Rosen GM. Light-dependent generation of superoxide from human erythrocytes. Photochem Photobiol. 1992;56:353-356.
70. Stahl W, Briviba K, Hamusch M, et al. Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis. 1997;18:89-92.
71. Liebler DC, Stratton SP, Kaysen KL. Antioxidant actions of β-carotene in liposomal and microsomal membranes: role of carotenoidmembrane incorporation and β-tocopherol. Arch Biochem Biophys. 1997;338:244-250.
72. Foote CS, Denny RW, Weaver L, Chang Y, Phil D, Peters J. Quenching of singlet oxygen. Ann N Y Acad Sci. 1970;171:139-148.
73. Sundelin SP, Nilsson SE, Brunk UT. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med. 2001;31:217-225.
74. Jackson GR, Owsley C, Cordle EP, Finley CD. Aging and scotopic sensitivity. Vision Res. 1998;38:3655-3662.
75. Barker FM. The Direct Spectral Transmittance of the Human Crystalline Lens as a Function of Age: FDA Report. Rockville, Md: National Press Office; 1991.
76. Boulton M. Aging of the retinal pigment epithelium. Prog Retin Eye Res. 1991;11:125-151.
77. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278-3296.
78. Mares JA, La Rowe TL, Blodi BA. Doctor, what vitamins should I take for my eyes? Arch Ophthalmol. 2004;122:628-635.
79. Mares J. Carotenoids and eye disease: epidemiological evidence. In: Krinsky NI, Mayne ST, Sies H, eds. Carotenoids in Health and Disease. New York, NY: Marcel Dekker Inc; 2004.
80. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and anti-oxidant vitamins. Am J Clin Nutr. 1995;62(suppl):1448S-1461S.
81. Feeney-Burns L, Hilderbrand ES, Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci. 1984;25:195-200.
82. Boulton M, Dontsov A, Jarvis-Evans J, Ostrovsky M, Svistunenko D. Lipofuscin is a photoinducible free radical generator. J Photochem Photobiol B. 1993;19:201-204.
83. Suter M, Reme C, Grimm C, et al. Age-related macular degeneration: the lipofuscin component N-retinyl-N-retinylidene ethanolamine detaches pro-apoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment cells. J Biol Chem. 2000;275:39625-39630.
84. Sparrow JR, Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci. 2001;42:1356-1362.
85. Sparrow JR, Nakanski K, Parish CA. The lipofuscin fluorophor A2E mediates blue light damage to retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981-1989.
86. Rozanowska M, Wessels J, Boulton M, et al. Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic Biol Med. 1998;24:1107-1112.
87. Shaban H, Borras C, Vina J, Richter C. Phosphatidylglycerol potently protects human retinal pigment epithelial cells against apoptosis induced by A2E, a compound suspected to cause age-related macular degeneration. Exp Eye Res. 2002;75:99-108.
88. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291-306.
89. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2002;240:666-671.
90. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
91. Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci. 1980;19:857-863.
92. Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci. 2004;45:3234-3243.
93. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM. Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2004;45:3244-3256.
94. Thomson LR, Toyoda Y, Delori FC, et al. Longterm dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp Eye Res. 2002;75:529-542.
95. Thomson LR, Toyoda Y, Langner A, et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci. 2002;43:3538-3549.
96. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one-year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57-62.
97. Seddon JM, Ajani UA, Sperduto R, et al; Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration [published correction appears in JAMA. 1995;273:622]. JAMA. 1994;272:1413-1420.
98. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-1708.
99. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
100. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80:368-371.
101. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122:883-892.
102. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995;113:1518-1523.
103. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
104. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 2002;109:2272-2278.